DSIB // DIRECTORY // HEA // REV 2026.10
CATEGORY 26
HEALTHCARE, PHARMACEUTICAL, BIOTECHNOLOGY & LIFE SCIENCES INTELLIGENCE
Strategic intelligence for healthcare and life-sciences organisations assessing institutional, supply-chain, investment, cyber and integrity risks.
CONNECTED INTELLIGENCE FOR HEALTHCARE AND LIFE-SCIENCES DECISIONS.
Independent, analytical and advisory. Services are delivered under defined mandates and are subject to applicable law, jurisdiction, client authorisation and professional obligations. DSIB does not act as a public authority or exercise statutory powers.
01
MANDATE
Connect documented institutional relationships and external developments to strategic risk decisions across healthcare delivery and life-sciences markets.
Connected intelligence for healthcare and life-sciences decisions.
02
SCOPE
Healthcare systems and providers; pharmaceuticals and biotechnology; devices and diagnostics; investment and counterparties; supply-chain integrity; health-security context and continuity; defensive cyber and fraud intelligence; recurring executive reporting.
03
CLIENTS
PRIMARY CLIENTS: HOSPITAL GROUPS, PHARMACEUTICAL COMPANIES, MEDICAL-DEVICE FIRMS, HEALTHCARE INVESTORS, DISTRIBUTORS AND PUBLIC HEALTH INSTITUTIONS.
SYSTEMS · PROVIDERS · INSTITUTIONAL CONTEXT
Examines healthcare-system developments, provider relationships and the external conditions affecting organisational decisions. Research helps accountable teams distinguish documented capacity and institutional change from unsupported commercial representations.
Intelligence supports strategy and risk assessment. Diagnosis, treatment, clinical decisions and patient-care priorities remain with licensed health professionals; this service does not assess individual patients.
INTELLIGENCE CAPABILITIES
01.01 HEALTHCARE SYSTEM STRUCTURE RESEARCH
01.02 PROVIDER OWNERSHIP AND GOVERNANCE MAPPING
01.03 PUBLIC HEALTHCARE CAPACITY CONTEXT ANALYSIS
01.04 HOSPITAL NETWORK EXPANSION MONITORING
01.05 HEALTHCARE FUNDING MODEL COMPARISON
01.06 PROVIDER PARTNERSHIP RELATIONSHIP RESEARCH
01.07 PUBLIC HEALTH REFORM DEVELOPMENT TRACKING
01.08 HEALTHCARE COMMISSIONING STAKEHOLDER MAPPING
01.09 INSTITUTIONAL SERVICE DEPENDENCY ASSESSMENT
01.10 PROVIDER FINANCIAL DISTRESS INDICATOR REVIEW
01.11 HOSPITAL CONSOLIDATION MARKET CONTEXT RESEARCH
01.12 HEALTHCARE ACCESS POLICY HORIZON SCANNING
01.13 PROVIDER CAPABILITY REPRESENTATION CORROBORATION
01.14 REGIONAL HEALTHCARE STRATEGY SCENARIO ANALYSIS
01.15 EXECUTIVE HEALTH-SYSTEM INTELLIGENCE BRIEFINGS
01.16 MATERIAL PROVIDER DEVELOPMENT ALERTS
DSIB-HEA-01
HEALTH-SYSTEM AND HEALTHCARE-PROVIDER INTELLIGENCE
MARKETS · DEVELOPERS · COMMERCIAL RELATIONSHIPS
Connects pharmaceutical and biotechnology market developments with the organisations, partnerships and institutional decisions behind them. Documented research supports strategy and integrity assessment while qualifying scientific and commercial uncertainty.
The service does not assess treatment suitability, validate efficacy or direct laboratory work. Scientific, clinical, regulatory and investment determinations require the appropriate qualified specialists.
INTELLIGENCE CAPABILITIES
02.01 PHARMACEUTICAL MARKET STRUCTURE ASSESSMENT
02.02 BIOTECHNOLOGY DEVELOPER BACKGROUND RESEARCH
02.03 PUBLIC DEVELOPMENT PIPELINE CONTEXT REVIEW
02.04 LIFE-SCIENCES LICENSING PARTNERSHIP MAPPING
02.05 BIOPHARMACEUTICAL ALLIANCE INTEGRITY RESEARCH
02.06 PUBLIC TRIAL REGISTRATION CHANGE MONITORING
02.07 PHARMACEUTICAL MARKET ACCESS POLICY RESEARCH
02.08 BIOTECHNOLOGY FUNDING RELATIONSHIP ANALYSIS
02.09 PUBLIC PRODUCT AUTHORISATION DEVELOPMENT TRACKING
02.10 RESEARCH SPONSOR INSTITUTIONAL BACKGROUND REVIEW
02.11 PHARMACEUTICAL COMPETITION LANDSCAPE MAPPING
02.12 BIOTECHNOLOGY COMMERCIAL CLAIM CORROBORATION
02.13 PUBLIC PATENT DISPUTE CONTEXT RESEARCH
02.14 LIFE-SCIENCES STRATEGIC DEPENDENCY ASSESSMENT
02.15 EXECUTIVE PHARMACEUTICAL SECTOR BRIEFINGS
02.16 MATERIAL BIOTECHNOLOGY MARKET CHANGE ALERTS
DSIB-HEA-02
PHARMACEUTICAL AND BIOTECHNOLOGY INTELLIGENCE
MANUFACTURERS · DISTRIBUTORS · MARKET CONTEXT
Researches medical-device and diagnostics businesses, their commercial relationships and public market developments. Intelligence supports supplier and strategic decisions by identifying evidence gaps, concentration and matters requiring specialist review.
Research does not certify device safety, diagnostic accuracy, product conformity or clinical suitability. Product testing and regulatory conclusions remain with authorised specialists and competent institutions.
INTELLIGENCE CAPABILITIES
03.01 MEDICAL DEVICE MANUFACTURER OWNERSHIP RESEARCH
03.02 DIAGNOSTICS COMPANY BACKGROUND ASSESSMENT
03.03 DEVICE DISTRIBUTOR RELATIONSHIP MAPPING
03.04 PUBLIC DEVICE RECALL CONTEXT REVIEW
03.05 DIAGNOSTICS MARKET STRUCTURE ANALYSIS
03.06 MEDICAL TECHNOLOGY PARTNERSHIP DUE DILIGENCE
03.07 PUBLIC DEVICE REGISTRATION STATUS RESEARCH
03.08 DEVICE SUPPLIER COMMERCIAL CLAIM CORROBORATION
03.09 DIAGNOSTICS REIMBURSEMENT POLICY MONITORING
03.10 MEDICAL EQUIPMENT SERVICE DEPENDENCY MAPPING
03.11 DEVICE SOFTWARE VENDOR BACKGROUND REVIEW
03.12 DIAGNOSTICS SECTOR LITIGATION RESEARCH
03.13 MEDICAL TECHNOLOGY PROCUREMENT MARKET ANALYSIS
03.14 DEVICE MARKET ENTRY CONTEXT ASSESSMENT
03.15 EXECUTIVE DIAGNOSTICS INDUSTRY BRIEFINGS
03.16 MEDICAL TECHNOLOGY COUNTERPARTY CHANGE MONITORING
DSIB-HEA-03
MEDICAL DEVICE AND DIAGNOSTICS INTELLIGENCE
OWNERSHIP · TRANSACTIONS · BUSINESS INTEGRITY
Builds an independent intelligence picture of healthcare investment targets, sponsors and counterparties. Research connects ownership, management history and material relationships to questions requiring transaction or governance-team assessment.
Findings supplement legal, financial and technical due diligence. They do not constitute investment suitability advice, valuation, clinical assurance or an approval to proceed with a transaction.
INTELLIGENCE CAPABILITIES
04.01 HEALTHCARE ACQUISITION TARGET INTEGRITY ASSESSMENT
04.02 HEALTH INVESTMENT SPONSOR BACKGROUND RESEARCH
04.03 PROVIDER BENEFICIAL OWNERSHIP RECONSTRUCTION
04.04 HEALTHCARE MANAGEMENT HISTORY CORROBORATION
04.05 LIFE-SCIENCES TARGET RELATED-PARTY MAPPING
04.06 HEALTHCARE TRANSACTION POLITICAL EXPOSURE REVIEW
04.07 MEDICAL BUSINESS LITIGATION CONTEXT ANALYSIS
04.08 HEALTHCARE COUNTERPARTY ADVERSE INFORMATION ASSESSMENT
04.09 INVESTMENT TARGET CUSTOMER CONCENTRATION REVIEW
04.10 HEALTHCARE PROJECT FINANCING RELATIONSHIP RESEARCH
04.11 PUBLIC HEALTHCARE INSOLVENCY RECORD ANALYSIS
04.12 HEALTH INVESTMENT CONFLICT-OF-INTEREST RESEARCH
04.13 HEALTHCARE DEAL REPRESENTATION EVIDENCE REVIEW
04.14 TRANSACTION INTELLIGENCE UNCERTAINTY REGISTERS
04.15 HEALTHCARE INVESTMENT COMMITTEE BRIEFINGS
04.16 PORTFOLIO INTEGRITY EVENT MONITORING
DSIB-HEA-04
HEALTHCARE INVESTMENT AND COUNTERPARTY INTELLIGENCE
SUPPLIERS · PRODUCT INTEGRITY · CONTINUITY
Maps medical supply relationships and documented integrity concerns to support accountable procurement and continuity teams. Intelligence distinguishes corroborated evidence from allegations and identifies questions requiring product, regulatory or investigative expertise.
Research does not authenticate medicines or devices, release products for use or determine patient safety. Suspected product-quality issues require appropriate specialist assessment and established reporting procedures.
INTELLIGENCE CAPABILITIES
05.01 MEDICAL SUPPLIER OWNERSHIP DUE DILIGENCE
05.02 PHARMACEUTICAL DISTRIBUTION NETWORK MAPPING
05.03 HEALTHCARE SUPPLY GEOGRAPHIC CONCENTRATION ANALYSIS
05.04 MEDICAL LOGISTICS PARTNER INTEGRITY RESEARCH
05.05 PUBLIC MEDICINE SHORTAGE DEVELOPMENT MONITORING
05.06 SUPPLIER DELIVERY DISTRESS INDICATOR ASSESSMENT
05.07 SUSPECTED COUNTERFEIT ALLEGATION CORROBORATION
05.08 AUTHORISED PRODUCT PROVENANCE DOCUMENT REVIEW
05.09 MEDICAL SUPPLY INTERMEDIARY RELATIONSHIP RESEARCH
05.10 PUBLIC PRODUCT DIVERSION CASE ANALYSIS
05.11 HEALTHCARE TENDER SUPPLIER BACKGROUND REVIEW
05.12 CRITICAL MEDICAL INPUT DEPENDENCY MAPPING
05.13 PUBLIC PRODUCT INTEGRITY ALERT SYNTHESIS
05.14 MEDICAL SUPPLY DISRUPTION SCENARIO ASSESSMENT
05.15 PROCUREMENT INTELLIGENCE EVIDENCE REGISTERS
05.16 SUPPLY INTEGRITY ESCALATION BRIEFINGS
DSIB-HEA-05
SUPPLY-CHAIN AND COUNTERFEIT-PRODUCT INTELLIGENCE
EXTERNAL INDICATORS · DEPENDENCIES · CONTINUITY
Synthesises authoritative public health developments and external disruption indicators for institutional continuity decisions. Research connects workforce, suppliers, infrastructure and geographic dependencies within an agreed strategic mandate.
This is non-clinical decision support, not disease forecasting, epidemiological surveillance or emergency medical direction. Official public-health guidance and accountable clinical and emergency procedures take precedence.
INTELLIGENCE CAPABILITIES
06.01 AUTHORITATIVE PUBLIC HEALTH ALERT MONITORING
06.02 HEALTHCARE CONTINUITY CONTEXT ASSESSMENT
06.03 ESSENTIAL HEALTH-SERVICE DEPENDENCY MAPPING
06.04 PUBLIC HEALTH EMERGENCY POLICY TRACKING
06.05 HEALTHCARE WORKFORCE DISRUPTION CONTEXT RESEARCH
06.06 MEDICAL SUPPLY RESILIENCE SCENARIO DEVELOPMENT
06.07 HEALTHCARE UTILITY DEPENDENCY ASSESSMENT
06.08 REGIONAL HEALTH-SERVICE DISRUPTION MONITORING
06.09 PUBLIC CROSS-BORDER HEALTH MEASURE RESEARCH
06.10 HEALTH INSTITUTION CRISIS STAKEHOLDER MAPPING
06.11 EXTERNAL HEALTH-SECURITY INDICATOR REVIEW
06.12 HEALTHCARE CONTINUITY ASSUMPTION REGISTERS
06.13 INSTITUTIONAL RESILIENCE INFORMATION GAP ANALYSIS
06.14 HEALTHCARE CRISIS REPORTING REQUIREMENT DESIGN
06.15 EXECUTIVE HEALTH-RESILIENCE SITUATION REPORTS
06.16 POST-DISRUPTION INTELLIGENCE LESSONS REVIEW
DSIB-HEA-06
HEALTH-SECURITY AND RESILIENCE INTELLIGENCE
DEFENSIVE CONTEXT · INTEGRITY · INFORMATION PROTECTION
Examines documented cyber developments, third-party dependencies and indicators of institutional misconduct affecting healthcare organisations. Lawful research supports responsible teams in triaging concerns and defining proportionate further enquiries.
No intrusion, interception or unauthorised access to health records is included. Allegations are qualified, sensitive information is minimised, and findings do not establish guilt or replace regulatory and legal processes.
INTELLIGENCE CAPABILITIES
07.01 HEALTHCARE CYBER THREAT CONTEXT ASSESSMENT
07.02 PUBLIC HEALTH-SECTOR CYBER INCIDENT RESEARCH
07.03 PROVIDER IMPERSONATION INDICATOR MONITORING
07.04 HEALTHCARE TECHNOLOGY VENDOR INCIDENT ANALYSIS
07.05 HEALTH DATA PROCESSOR CORPORATE DUE DILIGENCE
07.06 CLIENT-AUTHORISED PROCUREMENT ANOMALY RESEARCH
07.07 HEALTHCARE INVOICE RELATIONSHIP CORROBORATION
07.08 MEDICAL REFERRAL CONFLICT-OF-INTEREST RESEARCH
07.09 PUBLIC HEALTHCARE FRAUD ENFORCEMENT REVIEW
07.10 INSTITUTIONAL FUNDING RELATIONSHIP MAPPING
07.11 HEALTHCARE CONTRACTOR INTEGRITY ASSESSMENT
07.12 AUTHORISED INCIDENT CHRONOLOGY DEVELOPMENT
07.13 HEALTH-SECTOR CREDENTIAL EXPOSURE CONTEXT REVIEW
07.14 SENSITIVE HEALTH INFORMATION GOVERNANCE CONTEXT ANALYSIS
07.15 HEALTHCARE INTEGRITY EVIDENCE GAP ASSESSMENT
07.16 DEFENSIVE INTELLIGENCE ESCALATION BRIEFINGS
DSIB-HEA-07
CYBER, FRAUD AND INSTITUTIONAL-INTEGRITY INTELLIGENCE
AGREED COVERAGE · EARLY WARNING · EXECUTIVE REPORTING
Provides a defined programme of recurring intelligence on healthcare markets, counterparties and external risk developments. Scheduled reporting and agreed escalation help institutional leaders maintain a documented view of material change.
Coverage, sources, reporting intervals and escalation responsibilities are defined by mandate. Monitoring cannot guarantee detection of every risk or substitute for clinical, compliance, safety or continuity responsibilities.
INTELLIGENCE CAPABILITIES
08.01 HEALTHCARE INTELLIGENCE REQUIREMENT SCOPING
08.02 LIFE-SCIENCES MONITORING PLAN DEVELOPMENT
08.03 HEALTH COUNTERPARTY WATCHLIST DESIGN
08.04 HEALTHCARE POLICY HORIZON-SCANNING REPORTS
08.05 MEDICAL MARKET CHANGE INDICATOR TRACKING
08.06 HEALTHCARE INTEGRITY EVENT TRIAGE
08.07 ESSENTIAL SUPPLY RISK ALERT COORDINATION
08.08 SCHEDULED HEALTH-SECTOR INTELLIGENCE SUMMARIES
08.09 HEALTHCARE THIRD-PARTY CHANGE REPORTING
08.10 EXECUTIVE HEALTHCARE RISK DASHBOARDS
08.11 BOARD-LEVEL HEALTH STRATEGY BRIEFINGS
08.12 INSTITUTIONAL CRISIS INTELLIGENCE COORDINATION
08.13 HEALTH INTELLIGENCE SOURCE RELIABILITY REVIEW
08.14 ANALYTICAL CONFIDENCE AND ASSUMPTION REGISTERS
08.15 HEALTHCARE INTELLIGENCE ESCALATION WORKFLOW REVIEW
08.16 HEALTH INTELLIGENCE PROGRAMME EVALUATION
DSIB-HEA-08